BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 33941661)

  • 1. A Role for VCP/p97 in the Processing of Drug-Stabilized TOP2-DNA Covalent Complexes.
    Swan RL; Cowell IG; Austin CA
    Mol Pharmacol; 2021 Jul; 100(1):57-62. PubMed ID: 33941661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small Molecule Inhibitors Confirm Ubiquitin-Dependent Removal of TOP2-DNA Covalent Complexes.
    Swan RL; Poh LLK; Cowell IG; Austin CA
    Mol Pharmacol; 2020 Sep; 98(3):222-233. PubMed ID: 32587095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of TDP2 on the Level of TOP2-DNA Complexes and SUMOylated TOP2-DNA Complexes.
    Lee KC; Swan RL; Sondka Z; Padget K; Cowell IG; Austin CA
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30011940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intercalating TOP2 Poisons Attenuate Topoisomerase Action at Higher Concentrations.
    Atwal M; Swan RL; Rowe C; Lee KC; Lee DC; Armstrong L; Cowell IG; Austin CA
    Mol Pharmacol; 2019 Oct; 96(4):475-484. PubMed ID: 31399497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressing proteasome mediated processing of topoisomerase II DNA-protein complexes preserves genome integrity.
    Sciascia N; Wu W; Zong D; Sun Y; Wong N; John S; Wangsa D; Ried T; Bunting SF; Pommier Y; Nussenzweig A
    Elife; 2020 Feb; 9():. PubMed ID: 32057297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms to Repair Stalled Topoisomerase II-DNA Covalent Complexes.
    Swan RL; Cowell IG; Austin CA
    Mol Pharmacol; 2022 Jan; 101(1):24-32. PubMed ID: 34689119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Requirements for MRN endonuclease processing of topoisomerase II-mediated DNA damage in mammalian cells.
    Sun Y; Soans E; Mishina M; Petricci E; Pommier Y; Nitiss KC; Nitiss JL
    Front Mol Biosci; 2022; 9():1007064. PubMed ID: 36213114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depletion of tyrosyl DNA phosphodiesterase 2 activity enhances etoposide-mediated double-strand break formation and cell killing.
    Kont YS; Dutta A; Mallisetty A; Mathew J; Minas T; Kraus C; Dhopeshwarkar P; Kallakury B; Mitra S; Üren A; Adhikari S
    DNA Repair (Amst); 2016 Jul; 43():38-47. PubMed ID: 27235629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FEN1 participates in repair of the 5'-phosphotyrosyl terminus of DNA single-strand breaks.
    Kametani Y; Takahata C; Narita T; Tanaka K; Iwai S; Kuraoka I
    Carcinogenesis; 2016 Jan; 37(1):56-62. PubMed ID: 26581212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloperoxidase Enhances Etoposide and Mitoxantrone-Mediated DNA Damage: A Target for Myeloprotection in Cancer Chemotherapy.
    Atwal M; Lishman EL; Austin CA; Cowell IG
    Mol Pharmacol; 2017 Jan; 91(1):49-57. PubMed ID: 27974636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual functions of the homeoprotein DLX4 in modulating responsiveness of tumor cells to topoisomerase II-targeting drugs.
    Trinh BQ; Ko SY; Barengo N; Lin SY; Naora H
    Cancer Res; 2013 Jan; 73(2):1000-10. PubMed ID: 23222298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of topoisomerase II stability and activity by ubiquitination and SUMOylation: clinical implications for cancer chemotherapy.
    Ma Y; North BJ; Shu J
    Mol Biol Rep; 2021 Sep; 48(9):6589-6601. PubMed ID: 34476738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valosin-containing Protein (VCP)/p97 Segregase Mediates Proteolytic Processing of Cockayne Syndrome Group B (CSB) in Damaged Chromatin.
    He J; Zhu Q; Wani G; Sharma N; Wani AA
    J Biol Chem; 2016 Apr; 291(14):7396-408. PubMed ID: 26826127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repair of trapped topoisomerase II covalent cleavage complexes: Novel proteasome-independent mechanisms.
    Tsuda M; Kitamasu K; Hosokawa S; Nakano T; Ide H
    Nucleosides Nucleotides Nucleic Acids; 2020; 39(1-3):170-184. PubMed ID: 31608820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular processing pathways contribute to the activation of etoposide-induced DNA damage responses.
    Fan JR; Peng AL; Chen HC; Lo SC; Huang TH; Li TK
    DNA Repair (Amst); 2008 Mar; 7(3):452-63. PubMed ID: 18206427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteasomal inhibition potentiates drugs targeting DNA topoisomerase II.
    Lee KC; Bramley RL; Cowell IG; Jackson GH; Austin CA
    Biochem Pharmacol; 2016 Mar; 103():29-39. PubMed ID: 26794000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-Wide CRISPR Screens Reveal ZATT as a Synthetic Lethal Target of TOP2-Poison Etoposide That Can Act in a TDP2-Independent Pathway.
    Park JM; Zhang H; Nie L; Wang C; Huang M; Feng X; Tang M; Chen Z; Xiong Y; Lee N; Li S; Yin L; Hart T; Chen J
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleolar translocation of human DNA topoisomerase II by ATP depletion and its disruption by the RNA polymerase I inhibitor BMH-21.
    Morotomi-Yano K; Yano KI
    Sci Rep; 2021 Nov; 11(1):21533. PubMed ID: 34728715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of topoisomerase 2 DNA-protein crosslink resolution.
    Riccio AA; Schellenberg MJ; Williams RS
    Cell Mol Life Sci; 2020 Jan; 77(1):81-91. PubMed ID: 31728578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VCP/p97 Extracts Sterically Trapped Ku70/80 Rings from DNA in Double-Strand Break Repair.
    van den Boom J; Wolf M; Weimann L; Schulze N; Li F; Kaschani F; Riemer A; Zierhut C; Kaiser M; Iliakis G; Funabiki H; Meyer H
    Mol Cell; 2016 Oct; 64(1):189-198. PubMed ID: 27716483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.